InCarey

InCarey is a China-based digital healthcare service platform offering comprehensive disease management services for patients with chronic and specialty diseases including oncology, central nervous system disorders, rheumatic bone diseases, and congenital heart diseases. The cloud-based platform enables one-on-one doctor-patient interaction, professional disease management services, nutrition follow-up management for postoperative patients, and an internet retail platform allowing patients to receive medicines for major diseases through e-commerce. InCarey raised a $30 million Series B+ round in September 2020 led by Long Hill Capital.